EPTIFIBATIDE
- Product NDC
- 16729-260
- 11-digit product format
- 167290260
- Labeler code
- 16729
- Product ID
- 16729-260_cdd40b82-74eb-3b46-e053-2995a90aeabd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Eptifibatide
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Accord Healthcare Inc.
- Application
- ANDA205557
- Marketing category
- ANDA
- Marketing start
- 2018-04-09
- Marketing end
- 0000-00-00
- Substance
- EPTIFIBATIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16729-260-03 | 16729026003 | 1 VIAL, SINGLE-USE in 1 CARTON (16729-260-03) > 10 mL in 1 VIAL, SINGLE-USE | 2018-04-09 | 0000-00-00 | No | No | Current |
| 16729-260-38 | 16729026038 | 1 VIAL, SINGLE-USE in 1 CARTON (16729-260-38) > 100 mL in 1 VIAL, SINGLE-USE | 2018-04-12 | 0000-00-00 | No | No | Current |